Sahu Ashutosh, Kumar Rajnish, Hussain Mumtaz, Gupta Ajit, Raghwendra K H
Department of Anesthesiology, Indira Gandhi Institute of Medical Sciences, Patna, Bihar, India.
Anesth Essays Res. 2016 Sep-Dec;10(3):655-660. doi: 10.4103/0259-1162.191109.
Regional anesthesia using paravertebral block has been suggested as an ideal adjunct to general anesthesia for modified radical mastectomy. Paravertebral block is an effective management of peri-operative pain for Modified radical mastectomy, however, there are no established guidelines regarding what is the most suitable strategy when varying drugs and dosages between different groups.
To evaluate the effectiveness of paravertebral block comparing the most frequently employed drugs in this procedure (bupivacaine vs ropivacaine).
Prospective randomized double blind study.
A total 70 ASA I and II adult female patients undergoing Modified radical mastectomy under paravertebral block followed by general anesthesia were randomly divided into two groups. The first group was administered 0.375% Ropivacaine in a dose 0.25 ml /kg in paravertebral block. The second group was administered bupivacaine 0.375% in dose 0.25 ml /kg in paravertebral block. Standard induction technique followed. Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), were recorded pre block, post block 5 min, post block 10 min, at skin incision, post skin incision initially at 5 interval for first 15 min till one hour, and every 30 min till end of surgery. Post-operative visual analogue score for pain was recorded at 1 hr, 6 hr and 24 hr.
Chi-square test (Fisher's exact test) for qualitative variables. Independent sample -test for quantitative data.
Ropivacaine and Bupivacaine had no difference in intraoperative analgesia as shown by intraoperative hemodynamic parameters. Bupivacaine got better post-operative VAS scores ( < 0.05) in mean and after first, 6 h and 24 h.
有人提出椎旁阻滞区域麻醉是改良根治性乳房切除术全身麻醉的理想辅助方法。椎旁阻滞是改良根治性乳房切除术围手术期疼痛的有效管理方法,然而,对于不同组之间药物和剂量不同时最合适的策略尚无既定指南。
比较该手术中最常用的两种药物(布比卡因与罗哌卡因),评估椎旁阻滞的有效性。
前瞻性随机双盲研究。
总共70例接受椎旁阻滞联合全身麻醉下改良根治性乳房切除术的ASA I级和II级成年女性患者被随机分为两组。第一组在椎旁阻滞中给予0.375%罗哌卡因,剂量为0.25 ml/kg。第二组在椎旁阻滞中给予0.375%布比卡因,剂量为0.25 ml/kg。采用标准诱导技术。记录阻滞前、阻滞后5分钟、阻滞后10分钟、皮肤切开时、皮肤切开后最初15分钟内每5分钟一次直至1小时、以及直至手术结束每30分钟一次时的心率(HR)、收缩压(SBP)、舒张压(DBP)。术后1小时、6小时和24小时记录疼痛的视觉模拟评分。
定性变量采用卡方检验(Fisher精确检验)。定量数据采用独立样本t检验。
术中血流动力学参数显示,罗哌卡因和布比卡因在术中镇痛方面无差异。布比卡因在术后平均、术后1小时、6小时和24小时的视觉模拟评分更好(P<0.05)。